Atlas Trials

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Clinical trial NCT01676961 · TERMINATED

Trial details

NCT number
NCT01676961
Sponsor
NYU Langone Health
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple MyelomaThrombocytopenia
Start date
2013-01-01
Primary completion
2015-11-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.